By Robert Hughes, R&D Fellow, and James Springer, R&D Director Developing and manufacturing a pharmaceutical drug product from clinical to commercial scale is a continuous process of balancing speed and risk. At times, rapid scale up could mean accepting more risk, however, with an experienced manufacturing partner, your team can explore strategies to drive efficient scale up alongside thorough risk mitigation.